Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 25,239 shares, a decline of 50.1% from the June 30th total of 50,577 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
Kissei Pharmaceutical Stock Performance
KSPHF stock remained flat at $25.77 during trading hours on Thursday. Kissei Pharmaceutical has a 1 year low of $23.23 and a 1 year high of $31.90. The company has a 50 day moving average of $25.77 and a 200-day moving average of $26.15.
About Kissei Pharmaceutical
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.
The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.
Read More
- Five stocks we like better than Kissei Pharmaceutical
- Powering Up: NextEra and Brookfield Build an Off-Grid Empire
- DoorDash’s Drone Certification Could Reshape Its Delivery Margins
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
